Copyright: ©Author(s) 2026.
World J Clin Oncol. Oct 24, 2026; 17(10): 125453
Published online Oct 24, 2026. doi: 10.5306/wjco.125453
Published online Oct 24, 2026. doi: 10.5306/wjco.125453
Table 3 Distribution of virulence factor accumulation by clinical stage, n (%)
| Virulence factor accumulation | Stage I (n = 50) | Stage II (n = 54) | Stage III (n = 18) | Stage IV (n = 37) | P value |
| 1 gene | 5 (10.0) | 2 (3.7) | 0 (0.0) | 5 (13.5) | |
| 2 genes | 5 (10.0) | 4 (7.4) | 5 (27.8) | 8 (21.6) | |
| 3 genes | 34 (68.0) | 36 (66.7) | 13 (72.2) | 19 (51.4) | |
| 4 genes | 6 (12.0) | 12 (22.2) | 0 (0.0) | 5 (13.5) | 0.045a |
- Citation: Mbuthia O, Mahjabeen I, Kayani M, Mehmood A, Obiero J, Matsumoto T, Bosire K, Mureithi M. Helicobacter pylori virulence gene expression defines a stage-associated transcriptional signature in gastric cancer. World J Clin Oncol 2026; 17(10): 125453
- URL: https://www.wjgnet.com/2218-4333/full/v17/i10/125453.htm
- DOI: https://dx.doi.org/10.5306/wjco.125453